|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:SKIV2L2-F2R (FusionGDB2 ID:82108) |
Fusion Gene Summary for SKIV2L2-F2R |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SKIV2L2-F2R | Fusion gene ID: 82108 | Hgene | Tgene | Gene symbol | SKIV2L2 | F2R | Gene ID | 23517 | 2149 |
| Gene name | Mtr4 exosome RNA helicase | coagulation factor II thrombin receptor | |
| Synonyms | Dob1|KIAA0052|Mtr4|SKIV2L2|fSAP118 | CF2R|HTR|PAR-1|PAR1|TR | |
| Cytomap | 5q11.2 | 5q13.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | exosome RNA helicase MTR4ATP-dependent RNA helicase DOB1ATP-dependent RNA helicase SKIV2L2ATP-dependent helicase SKIV2L2Ski2 like RNA helicase 2TRAMP-like complex helicasefunctional spliceosome-associated protein 118superkiller viralicidic activity | proteinase-activated receptor 1protease-activated receptor 1 | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | . | P55085 | |
| Ensembl transtripts involved in fusion gene | ENST00000504388, ENST00000230640, ENST00000545714, | ENST00000319211, ENST00000505600, | |
| Fusion gene scores | * DoF score | 34 X 12 X 8=3264 | 3 X 3 X 2=18 |
| # samples | 15 | 3 | |
| ** MAII score | log2(15/3264*10)=-4.44360665147561 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: SKIV2L2 [Title/Abstract] AND F2R [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | SKIV2L2(54603975)-F2R(76028139), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | SKIV2L2-F2R seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. SKIV2L2-F2R seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | SKIV2L2 | GO:0006401 | RNA catabolic process | 29906447 |
| Tgene | F2R | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing | 9639571 |
| Tgene | F2R | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 10692450 |
| Tgene | F2R | GO:0007200 | phospholipase C-activating G protein-coupled receptor signaling pathway | 20164183 |
| Tgene | F2R | GO:0008285 | negative regulation of cell proliferation | 10692450 |
| Tgene | F2R | GO:0009611 | response to wounding | 9639571 |
| Tgene | F2R | GO:0030168 | platelet activation | 9038223 |
| Tgene | F2R | GO:0030193 | regulation of blood coagulation | 17848177 |
| Tgene | F2R | GO:0030194 | positive regulation of blood coagulation | 9038223 |
| Tgene | F2R | GO:0032967 | positive regulation of collagen biosynthetic process | 9639571 |
| Tgene | F2R | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | 10692450 |
| Tgene | F2R | GO:0043410 | positive regulation of MAPK cascade | 17848177 |
| Tgene | F2R | GO:0045893 | positive regulation of transcription, DNA-templated | 17848177 |
| Tgene | F2R | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 1672265 |
| Tgene | F2R | GO:2000484 | positive regulation of interleukin-8 secretion | 17404307 |
| Tgene | F2R | GO:2000778 | positive regulation of interleukin-6 secretion | 11447194 |
| Fusion gene breakpoints across SKIV2L2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across F2R (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | PRAD | TCGA-J4-A83I-01A | SKIV2L2 | chr5 | 54603975 | - | F2R | chr5 | 76028139 | + |
Top |
Fusion Gene ORF analysis for SKIV2L2-F2R |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 3UTR-3CDS | ENST00000504388 | ENST00000319211 | SKIV2L2 | chr5 | 54603975 | - | F2R | chr5 | 76028139 | + |
| 3UTR-intron | ENST00000504388 | ENST00000505600 | SKIV2L2 | chr5 | 54603975 | - | F2R | chr5 | 76028139 | + |
| 5CDS-intron | ENST00000230640 | ENST00000505600 | SKIV2L2 | chr5 | 54603975 | - | F2R | chr5 | 76028139 | + |
| 5CDS-intron | ENST00000545714 | ENST00000505600 | SKIV2L2 | chr5 | 54603975 | - | F2R | chr5 | 76028139 | + |
| Frame-shift | ENST00000545714 | ENST00000319211 | SKIV2L2 | chr5 | 54603975 | - | F2R | chr5 | 76028139 | + |
| In-frame | ENST00000230640 | ENST00000319211 | SKIV2L2 | chr5 | 54603975 | - | F2R | chr5 | 76028139 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000230640 | SKIV2L2 | chr5 | 54603975 | - | ENST00000319211 | F2R | chr5 | 76028139 | + | 3856 | 388 | 273 | 1577 | 434 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000230640 | ENST00000319211 | SKIV2L2 | chr5 | 54603975 | - | F2R | chr5 | 76028139 | + | 0.00166897 | 0.998331 |
Top |
Fusion Genomic Features for SKIV2L2-F2R |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for SKIV2L2-F2R |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:54603975/chr5:76028139) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | F2R |
| FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Receptor for trypsin and trypsin-like enzymes coupled to G proteins (PubMed:28445455). Its function is mediated through the activation of several signaling pathways including phospholipase C (PLC), intracellular calcium, mitogen-activated protein kinase (MAPK), I-kappaB kinase/NF-kappaB and Rho (PubMed:28445455). Can also be transactivated by cleaved F2R/PAR1. Involved in modulation of inflammatory responses and regulation of innate and adaptive immunity, and acts as a sensor for proteolytic enzymes generated during infection. Generally is promoting inflammation. Can signal synergistically with TLR4 and probably TLR2 in inflammatory responses and modulates TLR3 signaling. Has a protective role in establishing the endothelial barrier; the activity involves coagulation factor X. Regulates endothelial cell barrier integrity during neutrophil extravasation, probably following proteolytic cleavage by PRTN3 (PubMed:23202369). Proposed to have a bronchoprotective role in airway epithelium, but also shown to compromise the airway epithelial barrier by interrupting E-cadherin adhesion (PubMed:10086357). Involved in the regulation of vascular tone; activation results in hypotension presumably mediated by vasodilation. Associates with a subset of G proteins alpha subunits such as GNAQ, GNA11, GNA14, GNA12 and GNA13, but probably not with G(o) alpha, G(i) subunit alpha-1 and G(i) subunit alpha-2. However, according to PubMed:21627585 can signal through G(i) subunit alpha. Believed to be a class B receptor which internalizes as a complex with arrestin and traffic with it to endosomal vesicles, presumably as desensitized receptor, for extended periods of time. Mediates inhibition of TNF-alpha stimulated JNK phosphorylation via coupling to GNAQ and GNA11; the function involves dissociation of RIPK1 and TRADD from TNFR1. Mediates phosphorylation of nuclear factor NF-kappa-B RELA subunit at 'Ser-536'; the function involves IKBKB and is predominantly independent of G proteins. Involved in cellular migration. Involved in cytoskeletal rearrangement and chemotaxis through beta-arrestin-promoted scaffolds; the function is independent of GNAQ and GNA11 and involves promotion of cofilin dephosphorylation and actin filament severing. Induces redistribution of COPS5 from the plasma membrane to the cytosol and activation of the JNK cascade is mediated by COPS5. Involved in the recruitment of leukocytes to the sites of inflammation and is the major PAR receptor capable of modulating eosinophil function such as proinflammatory cytokine secretion, superoxide production and degranulation. During inflammation promotes dendritic cell maturation, trafficking to the lymph nodes and subsequent T-cell activation. Involved in antimicrobial response of innate immune cells; activation enhances phagocytosis of Gram-positive and killing of Gram-negative bacteria. Acts synergistically with interferon-gamma in enhancing antiviral responses. Implicated in a number of acute and chronic inflammatory diseases such as of the joints, lungs, brain, gastrointestinal tract, periodontium, skin, and vascular systems, and in autoimmune disorders. {ECO:0000269|PubMed:10086357, ECO:0000269|PubMed:10725339, ECO:0000269|PubMed:11413129, ECO:0000269|PubMed:11441110, ECO:0000269|PubMed:11447194, ECO:0000269|PubMed:11714832, ECO:0000269|PubMed:12832443, ECO:0000269|PubMed:15155775, ECO:0000269|PubMed:16359518, ECO:0000269|PubMed:16410250, ECO:0000269|PubMed:16478888, ECO:0000269|PubMed:16714334, ECO:0000269|PubMed:17404307, ECO:0000269|PubMed:17500066, ECO:0000269|PubMed:18424071, ECO:0000269|PubMed:18453611, ECO:0000269|PubMed:18474671, ECO:0000269|PubMed:18622013, ECO:0000269|PubMed:19494303, ECO:0000269|PubMed:19781631, ECO:0000269|PubMed:19864598, ECO:0000269|PubMed:19865078, ECO:0000269|PubMed:20826780, ECO:0000269|PubMed:21501162, ECO:0000269|PubMed:23202369, ECO:0000269|PubMed:28445455}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 57_60 | 29 | 426.0 | Compositional bias | Note=Asp/Glu-rich (acidic) | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 129_137 | 29 | 426.0 | Topological domain | Cytoplasmic | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 158_176 | 29 | 426.0 | Topological domain | Extracellular | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 199_218 | 29 | 426.0 | Topological domain | Cytoplasmic | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 240_268 | 29 | 426.0 | Topological domain | Extracellular | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 289_311 | 29 | 426.0 | Topological domain | Cytoplasmic | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 335_350 | 29 | 426.0 | Topological domain | Extracellular | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 375_425 | 29 | 426.0 | Topological domain | Cytoplasmic | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 42_102 | 29 | 426.0 | Topological domain | Extracellular | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 103_128 | 29 | 426.0 | Transmembrane | Helical%3B Name%3D1 | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 138_157 | 29 | 426.0 | Transmembrane | Helical%3B Name%3D2 | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 177_198 | 29 | 426.0 | Transmembrane | Helical%3B Name%3D3 | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 219_239 | 29 | 426.0 | Transmembrane | Helical%3B Name%3D4 | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 269_288 | 29 | 426.0 | Transmembrane | Helical%3B Name%3D5 | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 312_334 | 29 | 426.0 | Transmembrane | Helical%3B Name%3D6 | |
| Tgene | F2R | chr5:54603975 | chr5:76028139 | ENST00000319211 | 0 | 2 | 351_374 | 29 | 426.0 | Transmembrane | Helical%3B Name%3D7 |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | SKIV2L2 | chr5:54603975 | chr5:76028139 | ENST00000230640 | - | 1 | 27 | 148_304 | 44 | 1043.0 | Domain | Helicase ATP-binding |
| Hgene | SKIV2L2 | chr5:54603975 | chr5:76028139 | ENST00000230640 | - | 1 | 27 | 405_577 | 44 | 1043.0 | Domain | Helicase C-terminal |
| Hgene | SKIV2L2 | chr5:54603975 | chr5:76028139 | ENST00000230640 | - | 1 | 27 | 252_255 | 44 | 1043.0 | Motif | Note=DEIH box |
| Hgene | SKIV2L2 | chr5:54603975 | chr5:76028139 | ENST00000230640 | - | 1 | 27 | 161_168 | 44 | 1043.0 | Nucleotide binding | ATP |
Top |
Fusion Gene Sequence for SKIV2L2-F2R |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >82108_82108_1_SKIV2L2-F2R_SKIV2L2_chr5_54603975_ENST00000230640_F2R_chr5_76028139_ENST00000319211_length(transcript)=3856nt_BP=388nt GCTGCCTGCCACACGCCAGGCGCCACGCGCCGCCCTCGCTCTTTATCCACTGAGCAGCTTATCCACTTTAGGTCGGAAAGGAAAGGAAAG AAAAGCAGGAAAAAAAAAAAAAGTCAGGGGAACATTTTTGTCGGCTGCGCGACTCGACTACTTTTGTCTCCTGCGGGCCACTGTTGAGCC TTCACGAGACGTCACTGTCTTCGGTCGCGGGGCATCGTGGGTAGGAGGGAGATTTGCTCTCACTGCTCCCAAAAATGGCGGACGCATTCG GAGATGAGCTGTTCAGCGTGTTCGAGGGCGACTCGACCACTGCGGCGGGAACCAAAAAAGACAAGGAAAAGGACAAGGGGAAATGGAAGG GGCCTCCAGGGTCTGCAGACAAGGCAGGAATCAAAAGCAACAAATGCCACCTTAGATCCCCGGTCATTTCTTCTCAGGAACCCCAATGAT AAATATGAACCATTTTGGGAGGATGAGGAGAAAAATGAAAGTGGGTTAACTGAATACAGATTAGTCTCCATCAATAAAAGCAGTCCTCTT CAAAAACAACTTCCTGCATTCATCTCAGAAGATGCCTCCGGATATTTGACCAGCTCCTGGCTGACACTCTTTGTCCCATCTGTGTACACC GGAGTGTTTGTAGTCAGCCTCCCACTAAACATCATGGCCATCGTTGTGTTCATCCTGAAAATGAAGGTCAAGAAGCCGGCGGTGGTGTAC ATGCTGCACCTGGCCACGGCAGATGTGCTGTTTGTGTCTGTGCTCCCCTTTAAGATCAGCTATTACTTTTCCGGCAGTGATTGGCAGTTT GGGTCTGAATTGTGTCGCTTCGTCACTGCAGCATTTTACTGTAACATGTACGCCTCTATCTTGCTCATGACAGTCATAAGCATTGACCGG TTTCTGGCTGTGGTGTATCCCATGCAGTCCCTCTCCTGGCGTACTCTGGGAAGGGCTTCCTTCACTTGTCTGGCCATCTGGGCTTTGGCC ATCGCAGGGGTAGTGCCTCTGCTCCTCAAGGAGCAAACCATCCAGGTGCCCGGGCTCAACATCACTACCTGTCATGATGTGCTCAATGAA ACCCTGCTCGAAGGCTACTATGCCTACTACTTCTCAGCCTTCTCTGCTGTCTTCTTTTTTGTGCCGCTGATCATTTCCACGGTCTGTTAT GTGTCTATCATTCGATGTCTTAGCTCTTCCGCAGTTGCCAACCGCAGCAAGAAGTCCCGGGCTTTGTTCCTGTCAGCTGCTGTTTTCTGC ATCTTCATCATTTGCTTCGGACCCACAAACGTCCTCCTGATTGCGCATTACTCATTCCTTTCTCACACTTCCACCACAGAGGCTGCCTAC TTTGCCTACCTCCTCTGTGTCTGTGTCAGCAGCATAAGCTGCTGCATCGACCCCCTAATTTACTATTACGCTTCCTCTGAGTGCCAGAGG TACGTCTACAGTATCTTATGCTGCAAAGAAAGTTCCGATCCCAGCAGTTATAACAGCAGTGGGCAGTTGATGGCAAGTAAAATGGATACC TGCTCTAGTAACCTGAATAACAGCATATACAAAAAGCTGTTAACTTAGGAAAAGGGACTGCTGGGAGGTTAAAAAGAAAAGTTTATAAAA GTGAATAACCTGAGGATTCTATTAGTCCCCACCCAAACTTTATTGATTCACCTCCTAAAACAACAGATGTACGACTTGCATACCTGCTTT TTATGGGAGCTGTCAAGCATGTATTTTTGTCAATTACCAGAAAGATAACAGGACGAGATGACGGTGTTATTCCAAGGGAATATTGCCAAT GCTACAGTAATAAATGAATGTCACTTCTGGATATAGCTAGGTGACATATACATACTTACATGTGTGTATATGTAGATGTATGCACACACA TATATTATTTGCAGTGCAGTATAGAATAGGCACTTTAAAACACTCTTTCCCCGCACCCCAGCAATTATGAAAATAATCTCTGATTCCCTG ATTTAATATGCAAAGTCTAGGTTGGTAGAGTTTAGCCCTGAACATTTCATGGTGTTCATCAACAGTGAGAGACTCCATAGTTTGGGCTTG TACCACTTTTGCAAATAAGTGTATTTTGAAATTGTTTGACGGCAAGGTTTAAGTTATTAAGAGGTAAGACTTAGTACTATCTGTGCGTAG AAGTTCTAGTGTTTTCAATTTTAAACATATCCAAGTTTGAATTCCTAAAATTATGGAAACAGATGAAAAGCCTCTGTTTTGATATGGGTA GTATTTTTTACATTTTACACACTGTACACATAAGCCAAAACTGAGCATAAGTCCTCTAGTGAATGTAGGCTGGCTTTCAGAGTAGGCTAT TCCTGAGAGCTGCATGTGTCCGCCCCCGATGGAGGACTCCAGGCAGCAGACACATGCCAGGGCCATGTCAGACACAGATTGGCCAGAAAC CTTCCTGCTGAGCCTCACAGCAGTGAGACTGGGGCCACTACATTTGCTCCATCCTCCTGGGATTGGCTGTGAACTGATCATGTTTATGAG AAACTGGCAAAGCAGAATGTGATATCCTAGGAGGTAATGACCATGAAAGACTTCTCTACCCATCTTAAAAACAACGAAAGAAGGCATGGA CTTCTGGATGCCCATCCACTGGGTGTAAACACATCTAGTAGTTGTTCTGAAATGTCAGTTCTGATATGGAAGCACCCATTATGCGCTGTG GCCACTCCAATAGGTGCTGAGTGTACAGAGTGGAATAAGACAGAGACCTGCCCTCAAGAGCAAAGTAGATCATGCATAGAGTGTGATGTA TGTGTAATAAATATGTTTCACACAAACAAGGCCTGTCAGCTAAAGAAGTTTGAACATTTGGGTTACTATTTCTTGTGGTTATAACTTAAT GAAAACAATGCAGTACAGGACATATATTTTTTAAAATAAGTCTGATTTAATTGGGCACTATTTATTTACAAATGTTTTGCTCAATAGATT GCTCAAATCAGGTTTTCTTTTAAGAATCAATCATGTCAGTCTGCTTAGAAATAACAGAAGAAAATAGAATTGACATTGAAATCTAGGAAA ATTATTCTATAATTTCCATTTACTTAAGACTTAATGAGACTTTAAAAGCATTTTTTAACCTCCTAAGTATCAAGTATAGAAAATCTTCAT GGAATTCACAAAGTAATTTGGAAATTAGGTTGAAACATATCTCTTATCTTACGAAAAAATGGTAGCATTTTAAACAAAATAGAAAGTTGC AAGGCAAATGTTTATTTAAAAGAGCAGGCCAGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGGTGGATCAC GAGGTCAGGAGATCGAGACCATCCTGGCTAACACGGTGAAACCCGTCTCTACTAAAAATGCAAAAAAAATTAGCCGGGCGTGGTGGCAGG CACCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAGACTGGCGTGAACCCAGGAGGCGGACCTTGTAGTGAGCCGAGATCGCGCCAC TGTGCTCCAGCCTGGGCAACAGAGCAAGACTCCATCTCAAAAAATAAAAATAAATAAAAAATAAAAAAATAAAAGAGCAAACTATTTCCA AATACCATAGAATAACTTACATAAAAGTAATATAACTGTATTGTAAGTAGAAGCTAGCACTGGTTTTATTAATTTAGTGACTATTCATTT TATCTAAATCAGTGAAGATTTACTGTCATTGTTTATTAGTCTGTATATATTAAAATATGATATCATTAATGTACTTACAAAATAGTATGT >82108_82108_1_SKIV2L2-F2R_SKIV2L2_chr5_54603975_ENST00000230640_F2R_chr5_76028139_ENST00000319211_length(amino acids)=434AA_BP=38 MSCSACSRATRPLRREPKKTRKRTRGNGRGLQGLQTRQESKATNATLDPRSFLLRNPNDKYEPFWEDEEKNESGLTEYRLVSINKSSPLQ KQLPAFISEDASGYLTSSWLTLFVPSVYTGVFVVSLPLNIMAIVVFILKMKVKKPAVVYMLHLATADVLFVSVLPFKISYYFSGSDWQFG SELCRFVTAAFYCNMYASILLMTVISIDRFLAVVYPMQSLSWRTLGRASFTCLAIWALAIAGVVPLLLKEQTIQVPGLNITTCHDVLNET LLEGYYAYYFSAFSAVFFFVPLIISTVCYVSIIRCLSSSAVANRSKKSRALFLSAAVFCIFIICFGPTNVLLIAHYSFLSHTSTTEAAYF -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for SKIV2L2-F2R |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SKIV2L2-F2R |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for SKIV2L2-F2R |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies